Series B - VentiRx Pharmaceuticals
Investment Firm
Overview
VentiRx Pharmaceuticals develops novel TLR8 therapeutics for the treatment of cancer, allergy, and respiratory and autoimmune diseases.
Announced Date
Sep 23, 2014
Funding Type
Series B
Highlights
Location
United States, North America
Social
N/A
Investor Lead
N/A
Participant Investors
5
Round Details and Background
VentiRx Pharmaceuticals raised $50602514 on 2014-09-23 in Series B
VentiRx Pharmaceuticals develops novel TLR8 therapeutics for the treatment of cancer, allergy, and respiratory and autoimmune diseases.
Company Funding History
4
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jan 01, 2006 |  Seed Round - VentiRx Pharmaceuticals | - | 2.3M | |
| Mar 06, 2007 | Series A - VentiRx Pharmaceuticals | 3 | - | 26.6M |
| Sep 23, 2014 | Series B - VentiRx Pharmaceuticals | 5 | - | 50.6M |
| Jan 13, 2010 | Series A - VentiRx Pharmaceuticals | 4 | - | 25.0M |
Recent Activity
There is no recent news or activity for this profile.